J. Schmidt

Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis

Tanaz A. Kermani, J. Schmidt, Cynthia S. Crowson et al. · Seminars in Arthritis and Rheumatism · 2011 · 305 citations · Full text

Autoimmune Disease, Vasculitis, Medicine +10

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Diagnostic Features, Treatment, and Outcomes of Takayasu Arteritis in a US Cohort of 126 Patients

J. Schmidt, Tanaz A. Kermani, A. Kirstin Bacani et al. · Mayo Clinic Proceedings · 2013 · 222 citations

Rheumatology, Us Cohort, Vasculitis +3

Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followup

J. Schmidt, Tanaz A. Kermani, A. Kirstin Bacani et al. · Arthritis Care & Research · 2012 · 137 citations

Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss

Denis Chatelain, P. Duhaut, J. Schmidt et al. · Annals of the Rheumatic Diseases · 2008 · 83 citations